Russia Releases Covid-19 Vaccine- “Sputnik V” Into Public! - 1st Nation To Finish Human Trials:

Russia has released the first batch of the Sputnik V vaccine for coronavirus disease declared by its health ministry said in a statement. The research has been completed now and the vaccine proved to be.

The vaccine was created by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, a medical institute located near Moscow, Xinhua news agency reported.

Reports also say that Russia will offer the vaccine to other countries once its own citizens are vaccinated, Health Minister Mikhail Murashko said this Wednesday. So far, Russia has a total of 917,884 cases, with 15,617 deaths and 729,411 recoveries.

The first vaccine is in the form of a solution for intramuscular administration, was carried out at the Burdenko Military Hospital.

Another vaccine, in the form of a powder for the preparation of a solution for intramuscular administration, was carried out at Sechenov First Moscow State Medical University.

The first stage research on the vaccine was carried out at Sechenov University ehich involved a group of 18 volunteers and the second group involved 20 volunteers. After vaccination, all volunteers were expected to remain in isolation in a hospital for 28 days. When COVID-19 vaccine tests were performed on a group of volunteers in Russia, it was observed that they were developing immunity to the coronavirus. Listening to this news other countries also geared up then!!!

Chinese firm Sinovac Biotech Ltd said its vaccine CoronaVac appeared to be safe for older people to mid-aged. CoronaVac is being tested in Brazil and Indonesia in final-stage human trials to evaluate whether it is effective and safe enough to obtain regulatory approvals for mass use. It has already been given to tens of thousands of people, including about 90% of Sinovac employees and their families, as part of China’s emergency inoculation scheme to protect people facing high infection risk.

United States, President Donald Trump said that the vaccine to treat the deadly disease may become available in October whereas a new experimental Covid-19 vaccine originating from the University of Oxford has begun human trials in Australia in partnership with the Serum Institute of India, the world’s largest vaccine manufacturer.

India: The Post Graduate Institute (PGI) Rohtak is set to begin the phase-2 human clinical trial of Bharat Biotech’s vaccine candidate, based on inactivated virus procured by ICMR, on Wednesday.

“We got permission from Bharat Biotech to start a phase-2 human clinical trial of their vaccine. We’ve 300 volunteers, aged between 12 years and 65- years, out of which screening of 15 has been completed,” Dr. OP Kalra, vice-chancellor, PGI Rohtak told the news agency.

Australia expects to receive its first batches of a potential COVID-19 vaccine in January, its prime minister Scott Morrison said.

Also, a new shot devised by a UK firm SpyBiotech has begun going into volunteers in phase I/ II trial in Australia run by the Serum Institute, which will eventually enroll several hundred participants, said Sumi Biswas, the company’s chief executive officer and a professor at Oxford’s Nuffield Department of Medicine.

SpyBiotech has an exclusive licensing agreement with the Serum Institute for the vaccine. The institute reached a licensing deal with AstraZeneca earlier this year to produce 1 billion doses of the Oxford shot developed by Gilbert.

So, now it would be interesting to see who ranks first in the Vaccine race!. However, unity is the ultimate target. Whichever country makes it to the finale is expected to help people across the world.

Let’s keep our fingers crossed and expect the best to happen.